L. Geng

发表

Targeting nucleophosmin 1 represents a rational strategy for radiation sensitization.

P. Crooks, T. Abbas, M. Freeman, 2014, International journal of radiation oncology, biology, physics.

Integrin αvβ3 antagonist Cilengitide enhances efficacy of radiotherapy in endothelial cell and non–small-cell lung cancer models

D. Hallahan, B. Lu, J. Albert, 2006 .

Inhibition of Poly(ADP-Ribose) Polymerase Enhances Cell Death and Improves Tumor Growth Delay in Irradiated Lung Cancer Models

David H. Johnson, K. W. Kim, B. Lu, 2007, Clinical Cancer Research.

Radiation induces an antitumour immune response to mouse melanoma

D. Hallahan, A. Fu, L. Geng, 2009, International journal of radiation biology.

Protein kinase B/Akt-dependent phosphorylation of glycogen synthase kinase-3beta in irradiated vascular endothelium.

D. Hallahan, E. Yazlovitskaya, L. Geng, 2006, Cancer research.

Combined blockade of EGFR and glutamine metabolism in preclinical models of colorectal cancer

J. Berlin, M. Washington, R. Coffey, 2020, Translational oncology.

Noninvasive assessment of cancer response to therapy

D. Hallahan, Hailun Wang, A. Fu, 2008, Nature Medicine.

Histone deacetylase inhibitor NVP-LAQ824 sensitizes human nonsmall cell lung cancer to the cytotoxic effects of ionizing radiation

D. Hallahan, A. Fu, J. Huamani, 2007, Anti-cancer drugs.

Effects of intercellular adhesion molecule 1 (ICAM-1) null mutation on radiation-induced pulmonary fibrosis and respiratory insufficiency in mice.

D. Hallahan, Y. Shyr, L. Geng, 2002, Journal of the National Cancer Institute.

Mitigation of oxygen-induced retinopathy in α2β1 integrin-deficient mice.

Richard D. Friedman, M. Zutter, J. Penn, 2014, Investigative ophthalmology & visual science.

Radiation-Mediated Control of Drug Delivery

D. Hallahan, A. Cmelak, W. Martin, 2001, American journal of clinical oncology.

Integrin alpha v beta 3 antagonist Cilengitide enhances efficacy of radiotherapy in endothelial cell and non-small-cell lung cancer models.

D. Hallahan, B. Lu, J. Albert, 2006, International journal of radiation oncology, biology, physics.

Targeting drug delivery to radiation-induced neoantigens in tumor microvasculature.

D. Hallahan, A. Cmelak, W. Martin, 2001, Journal of controlled release : official journal of the Controlled Release Society.

Indolyl‐quinuclidinols inhibit ENOX activity and endothelial cell morphogenesis while enhancing radiation‐mediated control of tumor vasculature

P. Crooks, D. M. Morré, D. Morré, 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Hedgehog signaling in the murine melanoma microenvironment

D. Hallahan, A. Fu, M. K. Cooper, 2007, Angiogenesis.

Phosphatidylinositol 3-Kinase / Akt Signaling in the Response of Vascular Endothelium to Ionizing Radiation 1

D. Hallahan, L. Geng, E. Donnelly, 2002 .

HIV protease inhibitors enhance the efficacy of irradiation.

D. Hallahan, C. Willey, A. Fu, 2007, Cancer research.

Pharmacological Blockade of ASCT2-dependent Glutamine Transport Leads To Anti-tumor Efficacy in Preclinical Models

Joe T. Sharick, J. Berlin, M. Washington, 2017, Nature Medicine.

A Specific Antagonist of the p110δ Catalytic Component of Phosphatidylinositol 3′-Kinase, IC486068, Enhances Radiation-Induced Tumor Vascular Destruction

D. Hallahan, K. Niermann, A. Fu, 2004, Cancer Research.

Radiation-Induced Tumor Vascular Destruction-Kinase , IC 486068 , Enhances ′ Phosphatidylinositol 3 Catalytic Component of δ A Specific Antagonist of the p 110 Updated

D. Hallahan, A. Fu, K. Cuneo, 2004 .

SU 11248 Maintenance Therapy Prevents Tumor Regrowth after Fractionated Irradiation of Murine Tumor Models 1

D. Hallahan, G. Mcmahon, D. Mendel, 2003 .

SRC family kinase inhibitor SU6656 enhances antiangiogenic effect of irradiation.

D. Hallahan, Y. Shyr, A. Fu, 2006, International journal of radiation oncology, biology, physics.

Integrin-mediated targeting of drug delivery to irradiated tumor blood vessels.

Christopher Scarfone, Todd Giorgio, D. Hallahan, 2003, Cancer cell.

DNA-dependent protein kinase is a molecular target for the development of noncytotoxic radiation-sensitizing drugs.

D. Hallahan, Heidi Chen, L. Geng, 2005, Cancer research.

DNA-Dependent Protein Kinase Is a Molecular Target for the Development of Noncytotoxic Radiation–Sensitizing Drugs

D. Hallahan, Heidi Chen, L. Geng, 2005 .

Bone marrow X kinase-mediated signal transduction in irradiated vascular endothelium.

D. Hallahan, C. Willey, D. Thotala, 2008, Cancer research.

p53 and p21 Are Major Cellular Determinants for DNA Topoisomerase I‐Mediated Radiation Sensitization in Mammalian Cells

D. Hallahan, M. Rothenberg, P. Scruggs, 2000, Annals of the New York Academy of Sciences.

Inhibition of vascular endothelial growth factor receptor signaling leads to reversal of tumor resistance to radiotherapy.

D. Hallahan, G. Mcmahon, P. Lin, 2001, Cancer research.

A new class of molecular targeted radioprotectors: GSK-3beta inhibitors.

D. Hallahan, E. Yazlovitskaya, D. Thotala, 2010, International journal of radiation oncology, biology, physics.

STI571 (Gleevec) improves tumor growth delay and survival in irradiated mouse models of glioblastoma.

D. Hallahan, Y. Shyr, D. Kim, 2006, International journal of radiation oncology, biology, physics.

The receptor tyrosine kinase inhibitor SU11248 impedes endothelial cell migration, tubule formation, and blood vessel formation in vivo, but has little effect on existing tumor vessels

D. Hallahan, Y. Shyr, A. Fu, 2004, Angiogenesis.

The Use of Tyrosine Kinase Inhibitors in Modifying the Response of Tumor Microvasculature to Radiotherapy

D. Hallahan, B. Lu, L. Geng, 2005, Technology in cancer research & treatment.

Phosphatidylinositol 3-kinase/Akt signaling in the response of vascular endothelium to ionizing radiation.

D. Hallahan, L. Geng, E. Donnelly, 2002, Cancer research.

SU11248 (sunitinib) sensitizes pancreatic cancer to the cytotoxic effects of ionizing radiation.

D. Hallahan, A. Chakravarthy, A. Fu, 2007, International journal of radiation oncology, biology, physics.

Histone deacetylase (HDAC) inhibitor LBH589 increases duration of gamma-H2AX foci and confines HDAC4 to the cytoplasm in irradiated non-small cell lung cancer.

D. Hallahan, P. Atadja, A. Fu, 2006, Cancer research.

SU11248 maintenance therapy prevents tumor regrowth after fractionated irradiation of murine tumor models.

Gerald McMahon, D. Hallahan, G. Mcmahon, 2003, Cancer research.

Betulin alleviates on myocardial inflammation in diabetes mice via regulating Siti1/NLRP3/NF-κB pathway.

Lin Zhou, L. Geng, Zhiyuan Yang, 2020, International immunopharmacology.

The Novel Chemical Entity YTR107 Inhibits Recruitment of Nucleophosmin to Sites of DNA Damage, Suppressing Repair of DNA Double-Strand Breaks and Enhancing Radiosensitization

P. Crooks, W. McDonald, M. Freeman, 2011, Clinical Cancer Research.

Inhibition of mammalian target of rapamycin or apoptotic pathway induces autophagy and radiosensitizes PTEN null prostate cancer cells.

K. W. Kim, B. Lu, J. Albert, 2006, Cancer research.

Radiosensitization of lung cancer by nutlin, an inhibitor of murine double minute 2

D. Hallahan, B. Lu, J. Albert, 2006, Molecular Cancer Therapeutics.

Vascular endothelial growth factor tyrosine kinase inhibitor AZD2171 and fractionated radiotherapy in mouse models of lung cancer.

B. Lu, J. Albert, A. Sandler, 2006, Cancer research.

Models of Lung Cancer Inhibitor AZD 2171 and Fractionated Radiotherapy in Mouse Vascular Endothelial Growth Factor Tyrosine Kinase

B. Lu, J. Albert, A. Sandler, 2006 .

Targeting NPM1 represents a rationale strategy for radiosensitization

P. Crooks, T. Abbas, M. Freeman, 2014 .

Cancer Therapy : Preclinical The Novel Chemical Entity YTR 107 Inhibits Recruitment of Nucleophosmin toSites ofDNADamage , SuppressingRepair of DNA Double-Strand Breaks and Enhancing Radiosensitization

P. Crooks, W. McDonald, M. Freeman, 2011 .

Immunopharmacology and toxicology of the plant flavonoid baohuoside-1 in mice.

L. Geng, W. Seow, G. Ping, 1994, International journal of immunopharmacology.

Sonographic Depiction of Changes of Tumor Vascularity in Response to Various Therapies

D. Hallahan, A. Fleischer, E. Donnelly, 2005, Ultrasound quarterly.

Cytosolic Phospholipase A2: Targeting Cancer through the Tumor Vasculature

D. Hallahan, A. Lyshchik, A. Linkous, 2009, Clinical Cancer Research.

Advances in Brief Inhibition of Vascular Endothelial Growth Factor Receptor Signaling Leads to Reversal of Tumor Resistance to Radiotherapy 1

D. Hallahan, G. Mcmahon, P. Lin, 2001 .

Effects of vascular endothelial growth factor receptor inhibitor SU5416 and prostacyclin on murine lung metastasis

A. Fu, K. Cuneo, L. Geng, 2007, Anti-cancer drugs.

Erratum: A specific antagonist of the p110δ catalytic component of phosphatidylinositol 3′-kinase, IC486068, enhances radiation-induced tumor vascular destruction (Cancer Research (July 2004) 64 (4893-4899)

D. Hallahan, K. Niermann, A. Fu, 2004 .

Noninvasive Assessment of Tumor Vasculature Response to Radiation‐Mediated, Vasculature‐Targeted Therapy Using Quantified Power Doppler Sonography

Cameron C. Jones, T. Yankeelov, D. Hallahan, 2006, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

Radiation-guided drug delivery to tumor blood vessels results in improved tumor growth delay.

D. Hallahan, A. Fu, L. Geng, 2004, Journal of controlled release : official journal of the Controlled Release Society.

Quantified power Doppler US of tumor blood flow correlates with microscopic quantification of tumor blood vessels.

E F Donnelly, D. Hallahan, A. Fleischer, 2001, Radiology.

Broad spectrum receptor tyrosine kinase inhibitor, SU6668, sensitizes radiation via targeting survival pathway of vascular endothelium.

D. Hallahan, H. Choy, G. Mcmahon, 2004, International journal of radiation oncology, biology, physics.

Dynamic heterogeneity and non-Gaussian statistics for acetylcholine receptors on live cell membrane

B. Ackerson, W. He, H. Song, 2016, Nature Communications.

Phosphatidylinositol 3-Kinase / Akt Signaling in the Response of Vascular Endothelium to Ionizing Radiation 1

D. Hallahan, L. Geng, E. Donnelly, 2002 .